*Sponsored
StockWireNews
Low Float (ISPC) Is Cranking In Pre-Market After Making An Approx. $1.50+ Move
November 7th
Greetings Readers,
(Nasdaq: ISPC) is cooking in pre-market.
Hitting a high of $6.60 (at the time of writing) before the bell, ISPC could start turning heads quickly today after making a $1.50+ approx. move from last night's after hours closing valuation of $4.86.
Remember, with a low float under 1Mn shares, volatility potential will need to be on high watch.
Also, take a look at the company's major news announcement from this morning as it could draw in a ton of attention.
Consider (Nasdaq: ISPC) for your radar this morning and check out the full report below.
-----
My November kick-off profile caught the breakout bug as it ran from a previous night's after hours close of $.435 all the way to a high of $.6702 one day later.
The resulting explosion of approximately 54% put that NYSE American profile in the recent champ category and had use focusing on a new breakout idea.
Popping-off with a move of approximately 66% intraday when I previously suggested it as a radar watch, this past champ displayed explosive potential.
And when you see this profile's float (under 1Mn shares), you'll understand why it again has top place on our watch-list going into Thursday's opening bell.
Drop what you're doing and consider putting this Nasdaq profile on your radar:
*iSpecimen Inc. (Nasdaq: ISPC)*
iSpecimen offers an online marketplace for human biospecimens, connecting scientists in commercial and non-pro-fit organizations with healthcare providers that have access to patients and specimens needed for medical discovery.
And several potential catalysts could create breakout buzz for ISPC. Check them out:
#1. - A Very Low Float Could Create A Volatile Scenario In Moments.
#2. - An Explosive Chart History Since Mid-September Needs To Be Taken Seriously.
#3. - Major Revenue Growth Announced For Q2 2024 (Increase of 76% YOY).
#4. - This Company Displays A Long Growth History That's Been Picking Up The Pace In Recent Years...
But more on those in a second...
Company Breakdown: iSpecimen Inc. (Nasdaq: ISPC)
iSpecimen was founded to address a critical challenge: how to efficiently connect life science researchers who need human biospecimens with the billions of specimens available in healthcare organizations worldwide.
Their ground-breaking iSpecimen Marketplace® aids in solving this problem, reinventing the biospecimen procurement process to help accelerate medical discovery.
No comments:
Post a Comment